Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy. (Q48122829)

8 February 2018

title

Enzymatic rationale and preclinical support for a potent protein kinase C beta inhibitor in cancer therapy. (English)

1 reference

8 February 2018

author name string

Teicher BA

1

1 reference

8 February 2018

Alvarez E

2

1 reference

8 February 2018

Mendelsohn LG

3

1 reference

8 February 2018

Ara G

4

1 reference

8 February 2018

Menon K

5

1 reference

8 February 2018

Ways DK

6

1 reference

8 February 2018

publication date

1 January 1999

1 reference

8 February 2018

Advances in Enzyme Regulation

published in

1 reference

8 February 2018

volume

39

1 reference

8 February 2018

page(s)

313-327

1 reference

8 February 2018

Angiogenesis: new aspects relating to its initiation and control.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

What, if anything, is an angiogenic factor?

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Regulation of tumor angiogenesis by organ-specific cytokines.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Angiogenic factors as tumor markers

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Clinical significance of the determination of angiogenic factors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

The activity and expression of thymidine phosphorylase in human solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Vascular endothelial growth factor stimulates tyrosine phosphorylation and recruitment to new focal adhesions of focal adhesion kinase and paxillin in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

A review of tissue inhibitor of metalloproteinases-3 (TIMP-3) and experimental analysis of its effect on primary tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Geometric resistance and microvascular network architecture of human colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

The Eugene M. Landis Award Lecture 1996. Delivery of molecular and cellular medicine to solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics-->mechanism(s) of interaction).

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Thalidomide is an inhibitor of angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Molecular mechanisms of developmental and tumor angiogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Prognostic value of vascular endothelial growth factor expression in gastric carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

The phosphorylated 1169-tyrosine containing region of flt-1 kinase (VEGFR-1) is a major binding site for PLCgamma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

(S)-13-[(dimethylamino)methyl]-10,11,14,15-tetrahydro-4,9:16, 21-dimetheno-1H, 13H-dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecene-1,3(2H)-d ione (LY333531) and related analogues: isozyme selective inhibitors of protein kinase C beta

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Preclinical studies of the combination of angiogenic inhibitors with cytotoxic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Influence of an anti-angiogenic treatment on 9L gliosarcoma: oxygenation and response to cytotoxic therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Regulation of c-jun gene expression in HL-60 leukemia cells by 1-beta-D-arabinofuranosylcytosine. Potential involvement of a protein kinase C dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Induction and phosphorylation of protein kinase C-alpha and mitogen-activated protein kinase by hypoxia and by radiation in Chinese hamster V79 cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Effects of bryostatin 1 and other pharmacological activators of protein kinase C on 1-[beta-D-arabinofuranosyl]cytosine-induced apoptosis in HL-60 human promyelocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Inhibition of radiation-induced apoptosis in vitro by tumor promoters

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

One Hundred and Twenty-Seven Cultured Human Tumor Cell Lines Producing Tumors in Nude Mice23

1 reference

https://api.crossref.org/works/10.1016%2FS0065-2571%2898%2900026-0

7 January 2021

10.1016/S0065-2571(98)00026-0

Identifiers

DOI

1 reference

8 February 2018

PubMed ID

10470381

1 reference

8 February 2018